This is an old revision of this page, as edited by Anradt (talk | contribs) at 10:12, 27 January 2011. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 10:12, 27 January 2011 by Anradt (talk | contribs)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.577 |
Chemical and physical data | |
Formula | C19H19N3O5S |
Molar mass | 401.436 g/mol g·mol |
3D model (JSmol) | |
Density | 1.49 g/cm |
Boiling point | 686.8 °C (1,268.2 °F) |
SMILES
| |
InChI
| |
(verify) |
Oxacillin sodium (trade name Bactocill) is a narrow spectrum beta-lactam antibiotic of the penicillin class.
It was developed by Beecham.
Uses
Oxacillin is a penicillinase-resistant β-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Another related compound is nafcillin. Since it is resistant to penicillinase enzymes, such as that produced by Staphylococcus aureus, it is widely used clinically in the US to treat penicillin-resistant Staphylococcus aureus. However, resistant strains called oxacillin-resistant Staphylococcus aureus (MRSA/ORSA) are highly prevalent in the U.S. and the U.K.
References
- David Greenwood (2008). Antimicrobial drugs: chronicle of a twentieth century medical triumph. Oxford University Press US. pp. 124–. ISBN 9780199534845. Retrieved 18 November 2010.
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |